AI assistant
Sending…
Anterix Inc. — Director's Dealing 2024
Oct 8, 2024
33018_dirs_2024-10-08_719a15e4-c0c5-49bb-bc82-f14208046d46.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2024-10-04
Reporting Person: Gerbrandt Ryan (Chief Operating Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-10-04 | Stock Option (Right to Buy) | $35.66 | A | 61462 | Acquired | 2034-10-04 | Common Stock (61462) | Direct |
Footnotes
F1: The option shares vest on the third anniversary of the grant date, subject to (i) the Reporting Person's continued service with the Issuer through this date and (ii) the Issuer's common stock achieving a specified price per share during the three-year period.
More from Anterix Inc.
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Feb 11
Interim / Quarterly Report
2026
Feb 11
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 19